Literature DB >> 10466866

Cervical spondylarthrotic myelopathy with early onset in Down's syndrome: five cases and a review of the literature.

G P Bosma1, M A van Buchem, J H Voormolen, F C van Biezen, O F Brouwer.   

Abstract

Progressive walking difficulties and bladder dysfunction may be attributed to Alzheimer disease or atlanto-axial subluxation in people with Down's syndrome (DS). The present authors describe five patients with DS suffering from the above symptoms as a result of cervical spondylarthrotic myelopathy. Clinical and radiological data were collected from all patients with DS who underwent surgery for cervical spondylarthrotic myelopathy at the Leiden University Medical Centre during the period between 1991 and 1995. Five patients with DS (four males and one female) were identified. Their mean age at diagnosis was 42 years. The main clinical features were weakness of the arms and legs, ataxic gait, hyperreflexia and bilateral Babinski signs. Radiological examination showed spondylarthrosis, compression of the spinal cord and myelomalacia. The mean delay in diagnosis was 3 years. All five individuals showed clinical stabilization after laminectomy. Cervical spondylarthrotic myelopathy seems a rather frequent disorder in DS, occurring at a relatively young age. Early diagnosis may prevent irreversible neurological deficits.

Entities:  

Mesh:

Year:  1999        PMID: 10466866     DOI: 10.1046/j.1365-2788.1999.00212.x

Source DB:  PubMed          Journal:  J Intellect Disabil Res        ISSN: 0964-2633


  3 in total

Review 1.  Risk factors for the development of degenerative cervical myelopathy: a review of the literature.

Authors:  Guillaume Baucher; Jelena Taskovic; Lucas Troude; Granit Molliqaj; Aria Nouri; Enrico Tessitore
Journal:  Neurosurg Rev       Date:  2021-11-30       Impact factor: 3.042

2.  C2/3 instability: unusual cause of cervical myelopathy in a child with Down syndrome.

Authors:  Amro Al-Habib; Ahmed AlAqeel
Journal:  Childs Nerv Syst       Date:  2012-10-30       Impact factor: 1.475

3.  New onset focal weakness in children with Down syndrome.

Authors:  Gordon Worley; Rolla Shbarou; Amy N Heffner; Karin M Belsito; George T Capone; Priya S Kishnani
Journal:  Am J Med Genet A       Date:  2004-07-01       Impact factor: 2.802

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.